UNSPSC 85816127: Introduction of monoclonal antibody into peripheral artery, percutaneous approach

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 85816127

Definition

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of monoclonal antibody into peripheral artery, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0530M

About UNSPSC 85816127

UNSPSC 85816127 Introduction of monoclonal antibody into peripheral artery, percutaneous approach — a Commodity code — does not align with the state and local procurement activity in the recent opportunities block. The recent opportunities under this code span virtual urgent care, medical services contracting, PACE operations, occupational health and wellness, cancer screening, employee wellness portals, opioid use disorder treatment and recovery, behavioral health services, EMS staffing and billing, inmate health services, and radiology reads across multiple issuing bodies (health plans, counties, state health authorities, city governments, school districts, and special-purpose districts). None of these solicitations involve monoclonal antibody introduction procedures or interventional vascular services; the code appears to have been applied incorrectly to a broad set of healthcare service procurements that do not match its clinical scope.

State and local governments are actively buying integrated primary and behavioral health services, occupational health screening and testing, emergency medical and crisis stabilization services, specialized medical evaluation (psychology, independent medical evaluation, cancer registry, radiology), harm-reduction and addiction services, employee wellness administration, temporary clinical staffing, and facility-based medical services across counties in California, Georgia, Nevada, Florida, Colorado, Texas, Illinois, Kansas, Missouri, Virginia, Oregon, New York, and the District of Columbia. The issuing bodies include county health departments and health systems (Santa Clara, San Mateo, Brevard, DeKalb, Forsyth, Seminole, Sarasota, Rockland, Solano), state health authorities and departments (Nevada Health Authority, Colorado Department of Human Services, Texas HHSC, New Jersey Department of Health, Illinois Secretary of State), municipalities (Phoenix, Ocala, Atlanta, Boulder County), and special-purpose districts (Inland Empire Health Plan, Sourcewell cooperative). Representative recent opportunities include the Nevada Health Authority's RFP for PACE operations (due December 10, 2026), the County of Santa Clara's RFQ for travel nurse staffing (due January 6, 2027), the City of Phoenix's comprehensive cancer screening services contract (due February 2, 2026), and Sedgwick County and the City of Wichita's multiple opioid use disorder treatment and recovery RFPs funded by settlement monies (due September 15, 2026). This code shows no relevant recent activity; the mismatch between the code's clinical procedure scope and the actual healthcare service procurements suggests a classification error in the opportunities data rather than active buying under the code's intended definition.

Quick answers

What is UNSPSC 85816127?

UNSPSC 85816127 is Introduction of monoclonal antibody into peripheral artery, percutaneous approach, a commodity in UNSPSC 85000000, Healthcare Services.

Which NIGP codes match UNSPSC 85816127?

UNSPSC 85816127 maps to 1 NIGP code, 94848 Health Care Services (Not Otherwise Classified).

On GovTribe

See everything under UNSPSC 85816127

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code